Joshua Kazam​

Joshua is a Co-Founder and Partner of Two River, where he has served as Partner since its inception in 2004. Prior to founding Two River, he served as Managing Director of a life science focused venture capital firm. Joshua is a Co-Founder, officer and director of Allogene Therapeutics Inc. Joshua was also a Co-Founder and Director of Kite Pharma where he served on the board until its acquisition by Gilead in 2017. He also serves on the Board of Directors of Capricor Therapeutics (NASDAQ: CAPR). Joshua also serves as a director of several privately held companies including Second Science and Hubble Contacts, and is a Co-Founder and Director of Vida Ventures.

Joshua is a Member of the Wharton School’s Undergraduate Executive Board and serves on the Board of Directors of the Desert Flower Foundation. Joshua received his B.S. in Economics from the Wharton School of the University of Pennsylvania.